Although considerable progress has been made in determining risk factors for psychosis in recent dec...
Psychoeducation appears to improve long-term medication adherence in patients with schizophrenia, le...
A study published in AJP in Advance suggests ABT-126—a selective alpha-7 (α7) nicotinic receptor par...
Analysis of the Recovery After Initial Schizophrenia Episode (RAISE) trial has found that coordinate...
A research team from Broad Institute and Harvard Medical School has identified an immune-system gene...
The development of new technologies to facilitate disease management is a burgeoning field, but expe...
Chronic, high-dose use of benzodiazepines among patients with schizophrenia appears to be associated...
Children born to mothers who take a high-dose choline supplement during pregnancy may be less likely...
Three neurobiologically distinct psychosis “biotypes” have been identified that appear to cross clin...












